-
Je něco špatně v tomto záznamu ?
Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment
T. Česák, J. Adamkov, P. Poczos, M. Kanta, A. Krajina, D. Krajíčková, R. Herzig, M. Vališ,
Jazyk angličtina Země Rakousko
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
RVO - FN HK 00179906
Ministerstvo Zdravotnictví Ceské Republiky - International
PROGRES Q40
Charles University - International
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- cévní malformace centrálního nervového systému chirurgie terapie MeSH
- endovaskulární výkony škodlivé účinky metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- neurochirurgické výkony škodlivé účinky metody MeSH
- pooperační komplikace epidemiologie MeSH
- senioři MeSH
- terapeutická embolizace škodlivé účinky metody MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
BACKGROUND: The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. METHODS: A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. RESULTS: The average age was 60.1 ± 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS ≤ 3 versus 60% of patients with mRS ≥ 4 and, in 57.1% of patients aged ≥ 60 versus in 30% of patients < 60 years (p > 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. CONCLUSIONS: The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045244
- 003
- CZ-PrNML
- 005
- 20200113081940.0
- 007
- ta
- 008
- 200109s2018 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00701-018-3672-z $2 doi
- 035 __
- $a (PubMed)30225811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Česák, T $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
- 245 10
- $a Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment / $c T. Česák, J. Adamkov, P. Poczos, M. Kanta, A. Krajina, D. Krajíčková, R. Herzig, M. Vališ,
- 520 9_
- $a BACKGROUND: The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. METHODS: A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. RESULTS: The average age was 60.1 ± 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS ≤ 3 versus 60% of patients with mRS ≥ 4 and, in 57.1% of patients aged ≥ 60 versus in 30% of patients < 60 years (p > 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. CONCLUSIONS: The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a cévní malformace centrálního nervového systému $x chirurgie $x terapie $7 D020785
- 650 _2
- $a terapeutická embolizace $x škodlivé účinky $x metody $7 D004621
- 650 _2
- $a endovaskulární výkony $x škodlivé účinky $x metody $7 D057510
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neurochirurgické výkony $x škodlivé účinky $x metody $7 D019635
- 650 _2
- $a pooperační komplikace $x epidemiologie $7 D011183
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Adamkov, J $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
- 700 1_
- $a Poczos, P $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
- 700 1_
- $a Kanta, M $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
- 700 1_
- $a Krajina, A $u Department of Radiology, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
- 700 1_
- $a Krajíčková, D $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Herzig, R $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Vališ, Martin $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic. martin.valis@fnhk.cz.
- 773 0_
- $w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 160, č. 12 (2018), s. 2439-2448
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30225811 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113082311 $b ABA008
- 999 __
- $a ok $b bmc $g 1483513 $s 1083917
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 160 $c 12 $d 2439-2448 $e 20180918 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir $x MED00009022
- GRA __
- $a RVO - FN HK 00179906 $p Ministerstvo Zdravotnictví Ceské Republiky $2 International
- GRA __
- $a PROGRES Q40 $p Charles University $2 International
- LZP __
- $a Pubmed-20200109